X
17Aug

UK Life Sciences and Healthcare Newsletter - August 2020: COVID-19 – How Have Listed Companies Fared?

Dechert LLP | | Return|
COVID-19 has had a significant financial impact on many listed companies and, in recent months, there has been a marked increase in equity capital raises by listed companies. As at 22 July 2020, there have been over 100 secondary equity fundraisings in excess of £10 million on the Main Market and AIM since the COVID lockdown period began. Some have had to raise emergency capital, on short notice and often at significant discounts, whereas others have sought to shore up their balance sheets as...
By: Dechert LLP
Source Url: https://www.jdsupra.com/legalnews/uk-life-sciences-and-healthcare-82301/

Related

Hearsay What? EDNY Finds That Class Certification Evidence Must Be Admissible

Lin v. Everyday Beauty is an Eastern District of New York decision addressing an issue that has divi...

Read More >

No Crystal Ball for the ADA: Future Disabilities Not Protected Under Act

On October 29, 2019, a panel of Seventh Circuit Appellate Court Judges held that the Americans with ...

Read More >

Philadelphia Zoning, Land Use, and Construction COVID-19 Update

State and City Government – General - With limited exceptions, all Philadelphia government buildin...

Read More >

California Law Creates New Risk Factor

Last year, California enacted AB 5 imposing the so-called A-B-C test for employee status under Calif...

Read More >

Third Point to pay monetary penalty to settle allegations of HSR Act violations

On 28 August 2019 investment advisor Third Point LLC (Third Point) and three funds under its control...

Read More >

COVID-19: Control of Foreign Direct Investments in France

Evidence is growing of a hardening of French public policy regarding the need for political control ...

Read More >